We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tinnitus and Arterial Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01333683
Recruitment Status : Unknown
Verified March 2015 by Ricardo Rodrigues Figueiredo, Faculdade de Medicina de Valenca.
Recruitment status was:  Enrolling by invitation
First Posted : April 12, 2011
Last Update Posted : March 6, 2015
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Many authors link tinnitus to arterial hypertension. The aim of this study is to establish a possible relationship between them, analyze the severity of tinnitus related to arterial hypertension and analyze a possible influence of ototoxic drugs used to treat arterial hypertension

Condition or disease
Tinnitus Hearing Loss Arterial Hypertension

Detailed Description:
Arterial hypertension has been cited as a possible tinnitus etiology. Vascular abnormalities associated with it may account for cochlear and central nervous system. However, a relationship between tinnitus and arterial hypertension has never been established. The aim of this study is to analyze this relationship, comparing groups with and without arterial hypertension and the incidence of tinnitus amongst them. Inclusion and exclusion criteria try to isolate arterial hypertension as the main etiological factor, as much as possible. Presbycusis, noise exposure, metabolical diseases and genetic factors will be ruled out. A comparison will be performed inside the arterial hypertension group between subgroups that use or not ototoxic medications, such as furosemide and beta-blockers

Study Design

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tinnitus and Arterial Hypertension.is There Any Relationship?
Study Start Date : April 2011
Estimated Primary Completion Date : April 2015
Estimated Study Completion Date : October 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tinnitus
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Control
Normal subjects
AH
Arterial hypertension patients


Outcome Measures

Primary Outcome Measures :
  1. Incidence of tinnitus - have tinnitus x don't have tinnitus [ Time Frame: Up to 6 months ]
    The purpose of this study is to compare tinnitus incidence between patients with and without arterial hypertension.


Secondary Outcome Measures :
  1. Severity of tinnitus - Tinnitus Handicap Inventory [ Time Frame: Up to 6 months ]
    Severity of tinnitus measured by Tinnitus Handicap Inventory, to evaluate differences between patients with and without arterial hypertension


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 49 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients agedd between 40 and 50
Criteria

Inclusion Criteria:

  • age between 40 and 50
  • arterial hypertension for group 1
  • at least 5 years standing arterial hypertension

Exclusion Criteria:

  • chronic noise exposure
  • metabolic diseases
  • family antecedents of hearing loss (except for presbycusis)
  • pregnant women
  • use of ototoxic drugs (except for anti-hypertensives)
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01333683


Locations
Brazil
Faculdade de Medicina de Valença
Valença, RJ, Brazil, 27660-000
Sponsors and Collaborators
Faculdade de Medicina de Valenca
Federal University of São Paulo
Investigators
Principal Investigator: Ricardo R Figueiredo, MD,MSc Otosul, Valença Medical School
More Information

Responsible Party: Ricardo Rodrigues Figueiredo, M.D, MSc, Faculdade de Medicina de Valenca
ClinicalTrials.gov Identifier: NCT01333683     History of Changes
Other Study ID Numbers: HAS
First Posted: April 12, 2011    Key Record Dates
Last Update Posted: March 6, 2015
Last Verified: March 2015

Keywords provided by Ricardo Rodrigues Figueiredo, Faculdade de Medicina de Valenca:
tinnitus
hearing loss
arterial hypertension
ototoxicity

Additional relevant MeSH terms:
Hypertension
Hearing Loss
Deafness
Tinnitus
Vascular Diseases
Cardiovascular Diseases
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms